Skip to content
NYLithoFast In Office Treatment
Home  /  For Referring Physicians

For referring physicians

Evidence-based, guideline-concordant, office-based shockwave lithotripsy with transparent patient-selection criteria. A straightforward referral pathway for your patients with stones.

Indications (per AUA 2026 guideline)

Shockwave lithotripsy is a guideline-endorsed option. The 2026 AUA guideline supports URS or SWL for distal ureteral stones ≤10 mm and for proximal ureteral stones <2 cm, with modality selection driven by stone and patient factors and shared decision-making.

Our selection criteria

  • Renal stones up to ~20 mm; distal ureteral stones ≤10 mm.
  • Stone density preferentially <~970–1000 HU on NCCT (denser stones triaged to URS).
  • Favorable location and skin-to-stone distance; lower-pole anatomy assessed individually.
  • Exclusions: untreated UTI, coagulopathy, pregnancy, untreated distal obstruction, AAA in the shock path.

Outcomes

Bring your imaging and hospital records. We review your stone’s size, location and density, your symptoms and your health, then recommend a plan. ESWL suitability and timing are individual.

What we send back to you

  • Procedure note and fluoroscopic images.
  • A clear follow-up imaging plan and stone-free assessment.
  • 24-hour urine and metabolic recommendations for recurrence prevention.

How to refer

Call us at (212) 991-9991, or have your patient send their CT for a candidacy review. We make it easy to get a fast, honest read on whether a given stone is a good ESWL candidate — and we'll tell you when it isn't.

Refer a patient

Call us directly, or have your patient reach out for a candidacy review of their imaging.

Call (212) 991-9991 Request an appointment

Selected references

  1. Surgical Management of Kidney and Ureteral Stones: AUA Guideline (2026), Parts I–III. J Urol.
  2. Aboumarzouk OM, et al. ESWL versus ureteroscopic management for ureteric calculi (Cochrane review).
  3. Ouzaid I, et al. 970 HU threshold for ESWL patient selection. BJU Int. 2012.
  4. Joshi HB, et al. Ureteral Stent Symptom Questionnaire validation. J Urol. 2003.
  5. PUrE trial — cost-effectiveness, ESWL vs. FURS for lower-pole stones. 2025.
Call the officeRequest an appointment